Cargando…

The Effects of Wenxin Keli on Left Ventricular Ejection Fraction and Brain Natriuretic Peptide in Patients with Heart Failure: A Meta-Analysis of Randomized Controlled Trials

Objective. To evaluate the beneficial and adverse effects of Wenxin Keli (WXKL), either alone or in combination with Western medicine, on the left ventricular ejection fraction (LVEF) and plasma brain natriuretic peptide (BNP) in the treatment of heart failure (HF). Methods. Seven major electronic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu, Xiong, Xingjiang, Wang, Chunmei, Wang, Chenggang, Zhang, Ying, Zhang, Xingyong, Gao, Yonghong, Xing, Yanhui, Li, Jun, Wang, Jie, Liu, Xiaoqiu, Xing, Yanwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020470/ https://www.ncbi.nlm.nih.gov/pubmed/24868236 http://dx.doi.org/10.1155/2014/242589

Ejemplares similares

The Effects of Wenxin Keli on P-Wave Dispersion and Maintenance of Sinus Rhythm in Patients with Paroxysmal Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
por: Chen, Yu, et al.
Publicado: (2013)

Effects of Wenxin Keli on the Action Potential and L-Type Calcium Current in Rats with Transverse Aortic Constriction-Induced Heart Failure
por: Chen, Yu, et al.
Publicado: (2013)

Wenxin-Keli Regulates the Calcium/Calmodulin-Dependent Protein Kinase II Signal Transduction Pathway and Inhibits Cardiac Arrhythmia in Rats with Myocardial Infarction
por: Xing, Yanwei, et al.
Publicado: (2013)

Clinical Safety and Efficacy of Wenxin Keli-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Systematic Review and Meta-analysis
por: Zheng, Rui, et al.
Publicado: (2018)

Systematic review and meta-analysis of randomized controlled trials on Wenxin keli
por: Wang, Xiaoyi, et al.
Publicado: (2016)

The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity
por: Li, Jie, et al.
Publicado: (2017)

An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation
por: Wang, Yuanping, et al.
Publicado: (2022)

Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli
por: Yao, Yusi, et al.
Publicado: (2020)

Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview
por: Tian, Guihua, et al.
Publicado: (2018)

Wenxin Keli for the Treatment of Arrhythmia—Systems Pharmacology and In Vivo Pharmacological Assessment
por: Li, Xiaofeng, et al.
Publicado: (2021)

Effects of Wenxin Keli on Cardiac Hypertrophy and Arrhythmia via Regulation of the Calcium/Calmodulin Dependent Kinase II Signaling Pathway
por: Yang, Xinyu, et al.
Publicado: (2017)

Wenxin Keli for atrial fibrillation: Protocol for a systematic review and meta-analysis
por: He, Zhuogen, et al.
Publicado: (2018)

The Effect of Wenxin Keli on the mRNA Expression Profile of Rabbits with Myocardial Infarction
por: Zheng, Min, et al.
Publicado: (2016)

Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats
por: Gong, Mengqi, et al.
Publicado: (2020)

Screening and Identification of Cardioprotective Compounds From Wenxin Keli by Activity Index Approach and in vivo Zebrafish Model
por: Liu, Hao, et al.
Publicado: (2018)

Effect of Wenxin Granule on Ventricular Remodeling and Myocardial Apoptosis in Rats with Myocardial Infarction
por: Wu, Aiming, et al.
Publicado: (2013)

Efficacy and safety of Wenxin Keli combined with metoprolol tartrate in the treatment of premature ventricular contractions: A systematic review and meta-analysis
por: Huang, Ping, et al.
Publicado: (2022)

Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
por: Zhang, Nixiao, et al.
Publicado: (2018)

Molecular Targets and Pathways Contributing to the Effects of Wenxin Keli on Atrial Fibrillation Based on a Network Pharmacology Approach
por: Zhang, Yujie, et al.
Publicado: (2020)

Cardiac CaMKIIδ and Wenxin Keli Prevents Ang II-Induced Cardiomyocyte Hypertrophy by Modulating CnA-NFATc4 and Inflammatory Signaling Pathways in H9c2 Cells
por: An, Na, et al.
Publicado: (2020)

Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study
por: Meng, Zhaowei, et al.
Publicado: (2015)

The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial
por: Hua, Wei, et al.
Publicado: (2015)

Comparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid β-oxidation in myocardial injury protection
por: Jiang, Miaomiao, et al.
Publicado: (2017)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy
por: Stachowiak, Paweł, et al.
Publicado: (2013)

Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway
por: Lv, Meng, et al.
Publicado: (2022)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Left ventricular ejection fraction as an independent predictor of poor outcome in acute intracerebral hemorrhage
por: Yang, Guang, et al.
Publicado: (2020)

Smaller left ventricular end-systolic diameter and lower ejection fraction at baseline associated with greater ejection fraction improvement after revascularization among patients with left ventricular dysfunction
por: Wang, Shaoping, et al.
Publicado: (2022)

How to standardize the measurement of left ventricular ejection fraction
por: Kusunose, Kenya, et al.
Publicado: (2021)

The effect of idiopathic premature ventricular complexes on left ventricular ejection fraction
por: Altıntaş, Bernas, et al.
Publicado: (2019)

Left ventricular strain patterns and their relationships with cardiac biomarkers in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction
por: Zhang, Lisha, et al.
Publicado: (2022)

Correlation of left atrial strain with left ventricular end-diastolic pressure in patients with normal left ventricular ejection fraction
por: Fan, Jia-Li, et al.
Publicado: (2020)

Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction
por: Zhang, Xinxin, et al.
Publicado: (2021)

Decoding molecular signature on heart of septic mice with distinct left ventricular ejection fraction
por: Zhang, Lina, et al.
Publicado: (2023)

Hyperdynamic left ventricular ejection fraction in the intensive care unit
por: Paonessa, Joseph R., et al.
Publicado: (2015)

Left Ventricular Ejection Fraction and Volumes: It Depends on the Imaging Method
por: Wood, Peter W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_diekbrmjauqi5l624mimturivp